Pharma-Bio Serv Inc (OTCMKTS:PBSV) Stock On Radar After Earnings Update

September 15, 2022

Project management, compliance, and technology transfer consultancy company Pharma-Bio Serv Inc (OTCMKTS:PBSV) could be one of the companies to look into this morning following recent developments. The company was in the news yesterday after it announced its revenues for the three-month and nine-month periods, both of which ended on July 31, 2022. Trading Data On Wednesday, PBSV stock ended flat at $0.7410 with more than 3.77K shares, compared to its…


Pharma-Bio Serv (OTCMKTS:PBSV) Stock Soars 14% After Quarterly Results

June 15, 2022

When it comes to the pharmaceutical industry, regulatory clearance is the most important thing considering the fact that companies can bleed cash if they don’t get the necessary approvals. Hence, there are now companies that are solely responsible for providing consultancy services for regulatory issues to companies in the pharmaceutical sector. Pharma-Bio Serv (OTCMKTS:PBSV) is one such company and it primarily offers its services in four major markets. Trading Data…